Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Transplanted stem cells show promise for mending broken hearts


Working with heart attack-stricken mice, a team of University of Wisconsin-Madison scientists has shown that embryonic stem cells may one day live up to their clinical promise.

In a paper to be published in the January 2006 issue of the Journal of Molecular and Cellular Cardiology, a team led by UW-Madison stem cell researcher and heart specialist Timothy J. Kamp reports that all-purpose embryonic stem cells, transplanted into mouse hearts damaged by experimentally induced heart attacks, shift gears and morph into functional forms of the major types of cells that compose the healthy heart.

The study’s results are important because they demonstrate that blank-slate embryonic stem cells can be introduced to damaged heart tissue, develop into heart muscle and into cells that form the heart’s blood vessels. If perfected, such therapy could provide a practical, less-invasive alternative to current therapies such as surgery, improve the quality of life for many patients and reduce the number of deaths attributed to heart disease, now estimated at about 700,000 deaths per year in the United States.

"Typically, when that heart muscle dies (as the result of heart attack), it is gone for good," says Kamp, a professor of medicine and physiology in the UW-Madison School of Medicine and Public Health.

In their experiments, when stem cells were introduced directly to tissue damaged by a heart attack, three critical types of cells formed: cardiomyocytes or heart muscle; vascular smooth muscle, the muscle that forms the bulk of the walls of blood vessels; and endothelial cells, the flat cells that line the interior surfaces of blood vessels in the heart and throughout the body’s circulatory system.

"There are multiple components," Kamp explains. "But (in these experiments) we see the three most important types of cells forming. It didn’t completely repair the heart, but it was encouraging."

Kamp emphasized that although results of the new study show promise for using stem cells to repair diseased and damaged tissue, clinical application remains a distant hope. Further studies in mice, primates and, ultimately, humans will be required to ensure efficacy and safety.

Composed mostly of muscle, the heart drives the circulatory system. When it is damaged by a heart attack, scar tissue forms and the heart struggles to do its job of pumping blood throughout the body. With enough tissue damage, congestive heart failure - often leading to death - can occur.

The new experiments were aimed at answering critical questions relative to repairing hearts that have been damaged by heart attacks: Would the cells be driven to repair the heart at the site of the injury, and what kinds of cells would they become?

The group’s finding showed that the cells did indeed migrate to the site of the injury and developed into the critical cell types. Perhaps most importantly, the transplanted cells improved the function of the damaged heart.

"The heart ballooned out less, and its ability to contract improved," Kamp says. "The transplanted cells seemed to respond to the area of active injury. There is something about the injury that favors engraftment and incorporation of those cells."

One intriguing result of the new study is that the implanted cells did not result in tumor formation, one of the primary safety concerns for stem cell therapy. Like cancer cells, embryonic stem cells have a capacity to reproduce indefinitely and scientists must perfect cell transplant methods that are safe before the therapy can be attempted in human patients.

Kamp says future studies will explore ways to refine the cell types used in treating heart disease to enhance safety. His group also plans to implant human cells in mice and non-human primates to further assess the viability of cell transplant therapy and issues of safety.

Timothy J. Kamp | EurekAlert!
Further information:

More articles from Life Sciences:

nachricht Novel mechanisms of action discovered for the skin cancer medication Imiquimod
21.10.2016 | Technische Universität München

nachricht Second research flight into zero gravity
21.10.2016 | Universität Zürich

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: New 3-D wiring technique brings scalable quantum computers closer to reality

Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.

"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...

Im Focus: Scientists develop a semiconductor nanocomposite material that moves in response to light

In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.

A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...

Im Focus: Diamonds aren't forever: Sandia, Harvard team create first quantum computer bridge

By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.

"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...

Im Focus: New Products - Highlights of COMPAMED 2016

COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.

In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...

Im Focus: Ultra-thin ferroelectric material for next-generation electronics

'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.

Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...

All Focus news of the innovation-report >>>



Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

Agricultural Trade Developments and Potentials in Central Asia and the South Caucasus

14.10.2016 | Event News

World Health Summit – Day Three: A Call to Action

12.10.2016 | Event News

Latest News

Resolving the mystery of preeclampsia

21.10.2016 | Health and Medicine

Stanford researchers create new special-purpose computer that may someday save us billions

21.10.2016 | Information Technology

From ancient fossils to future cars

21.10.2016 | Materials Sciences

More VideoLinks >>>